Aggressive control of HIV viremia and cardiac risk factors and abstinence from unhealthy
behaviors remain treatment pillars to prevent heart failure and arrhythmic complications. The …

Increasing global access to human immunodeficiency virus (HIV) testing and treatment has
transformed HIV into a chronic disease for many of the over 40 million people with HIV …

Objectives: The aim of this study was to determine the incidence of sudden cardiac death
(SCD) among persons living with human immunodeficiency virus infection (PHIV) with heart …

Background Persons living with HIV (PLHIV) have an increased risk of heart failure (HF).
However, little is known about outcomes among PLHIV with HF. The study aim was to …

Patients with human immunodeficiency virus (HIV) infection are at increased risk of
cardiovascular disease, but studies on HIV as a risk factor for cardiac arrest in the general …

Objectives: This study sought to assess the safety of carvedilol therapy among heart failure
(HF) patients with a cocaine-use disorder (CUD). Background: Although carvedilol therapy is …

Objectives This study sought to investigate outcomes of heart failure (HF) in veterans living
with human immunodeficiency virus (HIV). Background Data on outcomes of HF among …

HIV‐infected individuals have an increased risk of sudden cardiac death compared to the
general population; yet the mechanisms underlying this increased risk remain unclear. The …

The association between human immunodeficiency virus (HIV) status and readmissions and
death outcomes in patients with established heart failure (HF) remains unclear. We …

Persons living with human immunodeficiency virus (PHIV) are twice as likely to develop
cardiovascular disease (CVD)(Online Ref. 1), including heart failure (HF)(Online Ref. 2) …